Negative regulation of muscle hypertrophy

pathway activity — cross-omics
GO:0014741Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of muscle hypertrophy pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are TP53BP1_S999, VIM_S72, and DAB2, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of muscle hypertrophy activity versus TP53BP1_S999 in LSCC (Pearson r = -0.54).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCTP53BP1_S999 →-0.848-0.067<.001.00235
BRCAVIM_S72 →+0.704+0.048<.001<.00135
BRCADAB2 →+0.306+0.032<.001<.00135
BRCADAB2_S723 →+0.517+0.035<.001<.00135
GBMSAP30BP →-0.281-0.058<.001<.00135
LSCCDOCK10_T1440 →+0.553+0.051.003<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0014741 vs TP53BP1_S999 — LSCC

Per-sample scatter of Negative regulation of muscle hypertrophy activity vs TP53BP1_S999 in LSCC.

Explore this scatter interactively →

Exploration